BIOTEST BIOTECH
68876738.176.68% ( +2.39 )
BIOTEST BIOTECH (688767)
Hangzhou Biotest Biotech Co.,Ltd. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instru...
- Open
- 35.05
- High
- 38.50
- Low
- 35.00
- Prev. Close
- 35.78
- Volume
- 49.31K
- Turnover
- 186.45M
- Avg Price
- 37.81
- Bid/Ask Ratio
- --
- Amplitude
- 9.78%
- 52wk High
- 50.28
- Volume Ratio
- 2.40
- Turnover Ratio
- 3.30%
News
- 同壁财经 · Jun 3 at 06:35 PM
A research report reveals the "game" of BIOTEST BIOTECH's brain-computer interface
- CoinLive · Apr 5 at 07:34 PM
AI TRENDS | Brain-Computer Interface Technology Set for Commercial Expansion by 2026
- 36Kr · Mar 23 at 06:57 PM
Brain-computer interfaces are becoming a reality, with over 100 institutions researching 5 concept stocks this year
- Wallstreetcn · Feb 13 at 12:14 AM
The A-share brain-computer interface concept is actively defying the trend, with BIOTEST BIOTECH rising over 10%, and Meihao Medical, Sanbo, APON, and Xiangyu Medical following suit
- 36Kr · Jan 5 at 01:07 AM
The three major A-share indices collectively closed higher, with the Shanghai Composite Index returning to 4,000 points
- Zhitong · Sep 11, 2025 at 05:23 PM
Multiple A-share companies reveal progress and product updates in brain-computer interface technology
